MicroRNA-126 inhibits invasion in non-small cell lung carcinoma cell lines.

PubWeight™: 2.15‹?› | Rank: Top 2%

🔗 View Article (PMID 18602365)

Published in Biochem Biophys Res Commun on July 03, 2008

Authors

M Crawford1, E Brawner, K Batte, L Yu, M G Hunter, G A Otterson, G Nuovo, C B Marsh, S P Nana-Sinkam

Author Affiliations

1: The Ohio State University Medical Center, Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, DHLRI 473 West 12th Avenue Room 201, Columbus, OH 43210, USA.

Articles citing this

MicroRNAs--the micro steering wheel of tumour metastases. Nat Rev Cancer (2009) 5.47

MiR-218 inhibits invasion and metastasis of gastric cancer by targeting the Robo1 receptor. PLoS Genet (2010) 3.12

MicroRNA regulatory networks in cardiovascular development. Dev Cell (2010) 3.09

Integrin signalling adaptors: not only figurants in the cancer story. Nat Rev Cancer (2010) 2.94

MicroRNA-451 regulates LKB1/AMPK signaling and allows adaptation to metabolic stress in glioma cells. Mol Cell (2010) 2.59

AngiomiRs--key regulators of angiogenesis. Curr Opin Genet Dev (2009) 2.40

Epigenetic regulation of miR-17~92 contributes to the pathogenesis of pulmonary fibrosis. Am J Respir Crit Care Med (2013) 2.16

A serum circulating miRNA diagnostic test to identify asymptomatic high-risk individuals with early stage lung cancer. EMBO Mol Med (2011) 1.83

miR-126 and miR-126* repress recruitment of mesenchymal stem cells and inflammatory monocytes to inhibit breast cancer metastasis. Nat Cell Biol (2013) 1.79

miRNA control of tumor cell invasion and metastasis. Int J Cancer (2010) 1.79

Crk and CrkL adaptor proteins: networks for physiological and pathological signaling. Cell Commun Signal (2009) 1.79

MicroRNA-143 regulates human osteosarcoma metastasis by regulating matrix metalloprotease-13 expression. Mol Ther (2011) 1.77

Hsa-miR-125a-3p and hsa-miR-125a-5p are downregulated in non-small cell lung cancer and have inverse effects on invasion and migration of lung cancer cells. BMC Cancer (2010) 1.72

miRNAs in lung cancer - studying complex fingerprints in patient's blood cells by microarray experiments. BMC Cancer (2009) 1.61

MicroRNA let-7f inhibits tumor invasion and metastasis by targeting MYH9 in human gastric cancer. PLoS One (2011) 1.51

Molecular biology of lung cancer: clinical implications. Clin Chest Med (2011) 1.47

MicroRNA-34a inhibits the proliferation and metastasis of osteosarcoma cells both in vitro and in vivo. PLoS One (2012) 1.45

MicroRNA control of epithelial-mesenchymal transition and metastasis. Cancer Metastasis Rev (2012) 1.34

MicroRNAs targeting oncogenes are down-regulated in pancreatic malignant transformation from benign tumors. PLoS One (2012) 1.27

MicroRNA delivery by cationic lipoplexes for lung cancer therapy. Mol Pharm (2011) 1.25

MicroRNAs in inflammatory lung disease--master regulators or target practice? Respir Res (2010) 1.24

The Roles of MicroRNAs in the Cancer Invasion-Metastasis Cascade. Cancer Microenviron (2010) 1.21

MicroRNAs in the pathogenesis of Lung Cancer. J Thorac Oncol (2009) 1.17

microRNA-155 silencing inhibits proliferation and migration and induces apoptosis by upregulating BACH1 in renal cancer cells. Mol Med Rep (2012) 1.15

Reduced miR-126 expression facilitates angiogenesis of gastric cancer through its regulation on VEGF-A. Oncotarget (2014) 1.12

Emerging roles for crk in human cancer. Genes Cancer (2010) 1.09

EGFR-TKI resistance in NSCLC patients: mechanisms and strategies. Am J Cancer Res (2014) 1.08

Up-regulation of microRNA-126 may contribute to pathogenesis of ulcerative colitis via regulating NF-kappaB inhibitor IκBα. PLoS One (2012) 1.06

PLK1-associated microRNAs are correlated with pediatric medulloblastoma prognosis. Childs Nerv Syst (2017) 1.05

A cluster of specified microRNAs in peripheral blood as biomarkers for metastatic non-small-cell lung cancer by stem-loop RT-PCR. J Cancer Res Clin Oncol (2011) 1.05

MetastamiRs: non-coding MicroRNAs driving cancer invasion and metastasis. Int J Mol Sci (2012) 1.04

Converging miRNA functions in diverse brain disorders: a case for miR-124 and miR-126. Exp Neurol (2011) 1.04

The emerging role of miRNAs in inflammatory bowel disease: a review. Therap Adv Gastroenterol (2015) 1.03

Expression of microRNA miR-126 and miR-200c is associated with prognosis in patients with non-small cell lung cancer. Virchows Arch (2014) 1.02

microRNAs and lung cancer: tumors and 22-mers. Cancer Metastasis Rev (2010) 1.01

MicroRNAs and lung cancers: from pathogenesis to clinical implications. Front Med (2012) 1.00

Down-regulation of miR-126 is associated with colorectal cancer cells proliferation, migration and invasion by targeting IRS-1 via the AKT and ERK1/2 signaling pathways. PLoS One (2013) 0.98

The predictive value of microRNA-126 in relation to first line treatment with capecitabine and oxaliplatin in patients with metastatic colorectal cancer. BMC Cancer (2012) 0.98

Strong inverse correlation between microRNA-125b and human papillomavirus DNA in productive infection. Diagn Mol Pathol (2010) 0.98

MicroRNAs in lung cancer. World J Methodol (2014) 0.97

Roles for crk in cancer metastasis and invasion. Genes Cancer (2012) 0.96

MicroRNAs and lung cancer: Biology and applications in diagnosis and prognosis. J Carcinog (2010) 0.96

The Tumor Cytosol miRNAs, Fluid miRNAs, and Exosome miRNAs in Lung Cancer. Front Oncol (2015) 0.96

MicroRNA-126 inhibits tumor cell growth and its expression level correlates with poor survival in non-small cell lung cancer patients. PLoS One (2012) 0.95

Identification of pathogenesis-related microRNAs in hepatocellular carcinoma by expression profiling. Oncol Lett (2012) 0.95

MicroRNAs in Cancer Biology and Therapy: Current Status and Perspectives. Genes Dis (2014) 0.94

MicroRNAs as novel predictive biomarkers and therapeutic targets in colorectal cancer. World J Gastroenterol (2014) 0.93

Oncogenic micro-RNAs and Renal Cell Carcinoma. Front Oncol (2014) 0.92

MicroRNAs - Important Molecules in Lung Cancer Research. Front Genet (2012) 0.90

Disruption of the expression and function of microRNAs in lung cancer as a result of epigenetic changes. Front Genet (2013) 0.89

Inherited polymorphisms in the RNA-mediated interference machinery affect microRNA expression and lung cancer survival. Br J Cancer (2010) 0.89

Alteration of processing induced by a single nucleotide polymorphism in pri-miR-126. Biochem Biophys Res Commun (2010) 0.88

SRC points the way to biomarkers and chemotherapeutic targets. Genes Cancer (2012) 0.88

miR-126 contributes to Parkinson's disease by dysregulating the insulin-like growth factor/phosphoinositide 3-kinase signaling. Neurobiol Aging (2014) 0.87

Concomitant dysregulation of microRNAs miR-151-3p and miR-126 correlates with improved survival in resected cholangiocarcinoma. HPB (Oxford) (2012) 0.87

Regulation of cancer metastasis by microRNAs. J Biomed Sci (2015) 0.86

microRNA signature for human pancreatic cancer invasion and metastasis. Exp Ther Med (2012) 0.85

Proteins that bind the Src homology 3 domain of CrkI have distinct roles in Crk transformation. Oncogene (2010) 0.84

High dose glargine alters the expression profiles of microRNAs in pancreatic cancer cells. World J Gastroenterol (2012) 0.84

MicroRNAs in Serum and Bile of Patients with Primary Sclerosing Cholangitis and/or Cholangiocarcinoma. PLoS One (2015) 0.84

Non-coding RNAs in lung cancer. Oncoscience (2014) 0.83

microRNAs: tiny RNA molecules, huge driving forces to move the cell. Protein Cell (2010) 0.83

Bostrycin inhibits proliferation of human lung carcinoma A549 cells via downregulation of the PI3K/Akt pathway. J Exp Clin Cancer Res (2011) 0.83

Diagnostic Value of Serum miR-182, miR-183, miR-210, and miR-126 Levels in Patients with Early-Stage Non-Small Cell Lung Cancer. PLoS One (2016) 0.82

Binding cavities and druggability of intrinsically disordered proteins. Protein Sci (2015) 0.80

Exosomes isolation and characterization in serum is feasible in non-small cell lung cancer patients: critical analysis of evidence and potential role in clinical practice. Oncotarget (2016) 0.78

MicroRNA-126-mediated control of cell fate in B-cell myeloid progenitors as a potential alternative to transcriptional factors. Proc Natl Acad Sci U S A (2013) 0.78

Small RNA Detection by in Situ Hybridization Methods. Int J Mol Sci (2015) 0.77

Role of Exosomal Noncoding RNAs in Lung Carcinogenesis. Biomed Res Int (2015) 0.77

MiR-126 regulates proliferation and invasion in the bladder cancer BLS cell line by targeting the PIK3R2-mediated PI3K/Akt signaling pathway. Onco Targets Ther (2016) 0.76

Strand and Cell Type-specific Function of microRNA-126 in Angiogenesis. Mol Ther (2016) 0.76

Keratin 19 as a key molecule in progression of human hepatocellular carcinomas through invasion and angiogenesis. BMC Cancer (2016) 0.75

MicroRNA expression profiles and clinicopathological implications in lung adenocarcinoma according to EGFR, KRAS, and ALK status. Oncotarget (2016) 0.75

MicroRNA expression profiling defines the impact of electronic cigarettes on human airway epithelial cells. Sci Rep (2017) 0.75

miR-126: a potential new key player in hypoxia and reperfusion? Ann Transl Med (2016) 0.75

miRNA in Macrophage Development and Function. Antioxid Redox Signal (2016) 0.75

Novel signaling collaboration between TGF-β and adaptor protein Crk facilitates EMT in human lung cancer. Oncotarget (2016) 0.75

MicroRNA Expression in Malignant Pleural Mesothelioma and Asbestosis: A Pilot Study. Dis Markers (2017) 0.75

MicroRNA profiling associated with non-small cell lung cancer: next generation sequencing detection, experimental validation, and prognostic value. Oncotarget (2017) 0.75

Articles by these authors

Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet (2013) 9.46

Aberrant CpG-island methylation has non-random and tumour-type-specific patterns. Nat Genet (2000) 8.58

Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency. Nat Genet (1999) 7.30

Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters. Science (2000) 6.73

Phosphorylation of histone H3 is required for proper chromosome condensation and segregation. Cell (1999) 4.83

Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction. Proc Natl Acad Sci U S A (1998) 4.67

Prediction of type I diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies. Diabetes (1996) 4.20

Total daily physical activity and the risk of AD and cognitive decline in older adults. Neurology (2012) 4.09

Crystal structure of the cytochrome bc1 complex from bovine heart mitochondria. Science (1997) 4.07

The Chk1 protein kinase and the Cdc25C regulatory pathways are targets of the anticancer agent UCN-01. J Biol Chem (2000) 3.49

Characterization of a recombinant plant monoclonal secretory antibody and preventive immunotherapy in humans. Nat Med (1998) 3.11

microRNA-29 can regulate expression of the long non-coding RNA gene MEG3 in hepatocellular cancer. Oncogene (2011) 3.02

Stable binding to E2F is not required for the retinoblastoma protein to activate transcription, promote differentiation, and suppress tumor cell growth. Genes Dev (1998) 3.01

Influence of smoking fewer cigarettes on exposure to tar, nicotine, and carbon monoxide. N Engl J Med (1986) 2.87

Renin increases mesangial cell transforming growth factor-beta1 and matrix proteins through receptor-mediated, angiotensin II-independent mechanisms. Kidney Int (2006) 2.85

GADD45 induction of a G2/M cell cycle checkpoint. Proc Natl Acad Sci U S A (1999) 2.80

Studies on cytochrome oxidase. Interactions of the cytochrome oxidase protein with phospholipids and cytochrome c. J Biol Chem (1975) 2.80

Pharmacological characterization of the cloned kappa-, delta-, and mu-opioid receptors. Mol Pharmacol (1994) 2.70

X-ray diffraction of actively shortening muscle. Proc Natl Acad Sci U S A (1976) 2.59

Molecular cloning and functional expression of a mu-opioid receptor from rat brain. Mol Pharmacol (1993) 2.54

Partially unfolded states of beta(2)-microglobulin and amyloid formation in vitro. Biochemistry (2000) 2.47

A pilot trial of G3139, a bcl-2 antisense oligonucleotide, and paclitaxel in patients with chemorefractory small-cell lung cancer. Ann Oncol (2002) 2.42

Targeted disruption of the galectin-3 gene results in attenuated peritoneal inflammatory responses. Am J Pathol (2000) 2.40

Inhibition of cyclin D-CDK4/CDK6 activity is associated with an E2F-mediated induction of cyclin kinase inhibitor activity. Proc Natl Acad Sci U S A (1996) 2.30

Selected ion monitoring method for determination of nicotine, cotinine and deuterium-labeled analogs: absence of an isotope effect in the clearance of (S)-nicotine-3',3'-d2 in humans. Biol Mass Spectrom (1991) 2.10

Human galectin-3 is a novel chemoattractant for monocytes and macrophages. J Immunol (2000) 2.06

Mutations in the ABC1 gene in familial HDL deficiency with defective cholesterol efflux. Lancet (1999) 2.02

Human immunodeficiency virus type 1 infection alters chemokine beta peptide expression in human monocytes: implications for recruitment of leukocytes into brain and lymph nodes. Proc Natl Acad Sci U S A (1996) 2.02

Antibiotic activity and characterization of BB-3497, a novel peptide deformylase inhibitor. Antimicrob Agents Chemother (2001) 2.01

Human immunodeficiency virus type 1 T-lymphotropic strains enter macrophages via a CD4- and CXCR4-mediated pathway: replication is restricted at a postentry level. J Virol (1998) 2.00

Linker histones are not essential and affect chromatin condensation in vivo. Cell (1995) 1.99

Reprogramming of the tumour microenvironment by stromal PTEN-regulated miR-320. Nat Cell Biol (2011) 1.98

Clinical benefit of continuing ALK inhibition with crizotinib beyond initial disease progression in patients with advanced ALK-positive NSCLC. Ann Oncol (2014) 1.97

Helper virus-free transfer of herpes simplex virus type 1 plasmid vectors into neural cells. J Virol (1996) 1.89

Hydrogenase measurement with photochemically reduced methyl viologen. J Bacteriol (1969) 1.85

Improved dual-energy material discrimination for dual-source CT by means of additional spectral filtration. Med Phys (2009) 1.85

Mesenchymal stem cell-based angiopoietin-1 gene therapy for acute lung injury induced by lipopolysaccharide in mice. J Pathol (2008) 1.84

Accumulation of RNA homologous to human papillomavirus type 16 open reading frames in genital precancers. J Virol (1988) 1.70

Number of autoantibodies (against insulin, GAD or ICA512/IA2) rather than particular autoantibody specificities determines risk of type I diabetes. J Autoimmun (1996) 1.68

KLF8 promotes human breast cancer cell invasion and metastasis by transcriptional activation of MMP9. Oncogene (2010) 1.65

Inhibitor binding changes domain mobility in the iron-sulfur protein of the mitochondrial bc1 complex from bovine heart. Proc Natl Acad Sci U S A (1998) 1.65

Tumor necrosis factor alpha in children with sickle cell disease in stable condition. J Natl Med Assoc (1997) 1.63

Pharmacogenomic analysis: correlating molecular substructure classes with microarray gene expression data. Pharmacogenomics J (2002) 1.63

miR-221/222 overexpession in human glioblastoma increases invasiveness by targeting the protein phosphate PTPμ. Oncogene (2011) 1.62

One third of HLA DQ2 homozygous patients with type 1 diabetes express celiac disease-associated transglutaminase autoantibodies. J Autoimmun (1999) 1.62

Identification of amino acid residues critical for aggregation of human CC chemokines macrophage inflammatory protein (MIP)-1alpha, MIP-1beta, and RANTES. Characterization of active disaggregated chemokine variants. J Biol Chem (1999) 1.62

Generation of superoxide anion by succinate-cytochrome c reductase from bovine heart mitochondria. J Biol Chem (1998) 1.61

The cloning and expression of the aroL gene from Escherichia coli K12. Purification and complete amino acid sequence of shikimate kinase II, the aroL-gene product. Biochem J (1986) 1.60

Biology's new Rosetta stone. Nature (1997) 1.59

The type I serine/threonine kinase receptor ActRIA (ALK2) is required for gastrulation of the mouse embryo. Development (1999) 1.59

Occult lumbar lateral spinal stenosis in neural foramina subjected to physiologic loading. AJNR Am J Neuroradiol (1996) 1.58

Late progression to diabetes and evidence for chronic beta-cell autoimmunity in identical twins of patients with type I diabetes. Diabetes (1995) 1.55

Antineutrophil cytoplasmic antibodies induce monocyte IL-8 release. Role of surface proteinase-3, alpha1-antitrypsin, and Fcgamma receptors. J Clin Invest (1997) 1.55

The cloning and sequence analysis of the aspC and tyrB genes from Escherichia coli K12. Comparison of the primary structures of the aspartate aminotransferase and aromatic aminotransferase of E. coli with those of the pig aspartate aminotransferase isoenzymes. Biochem J (1986) 1.55

Pathologic evaluation of sentinel lymph nodes in colorectal carcinoma. Arch Pathol Lab Med (2000) 1.55

Small nucleolar RNA 42 acts as an oncogene in lung tumorigenesis. Oncogene (2011) 1.54

Intrarectal administration of mCRAMP-encoding plasmid reverses exacerbated colitis in Cnlp(-/-) mice. Gene Ther (2012) 1.53

ICA512 autoantibody radioassay. Diabetes (1995) 1.52

Minor tobacco alkaloids as biomarkers for tobacco use: comparison of users of cigarettes, smokeless tobacco, cigars, and pipes. Am J Public Health (1999) 1.52

Processing and maturation of flavocytochrome b558 include incorporation of heme as a prerequisite for heterodimer assembly. J Biol Chem (2000) 1.51

Macrophage colony-stimulating factor promotes cell survival through Akt/protein kinase B. J Biol Chem (1999) 1.51

Heterogeneity of type I diabetes: analysis of monozygotic twins in Great Britain and the United States. Diabetologia (2001) 1.49

Prognosis evaluation in alpha-fetoprotein negative hepatocellular carcinoma after hepatectomy: comparison of five staging systems. Eur J Surg Oncol (2010) 1.49

Acute kidney injury prediction following elective cardiac surgery: AKICS Score. Kidney Int (2007) 1.49

Fano resonance for Anderson impurity systems. Phys Rev Lett (2004) 1.48

Lack of association between early childhood immunizations and beta-cell autoimmunity. Diabetes Care (1999) 1.47

Reduced tar, nicotine, and carbon monoxide exposure while smoking ultralow- but not low-yield cigarettes. JAMA (1986) 1.45

T lymphocytes play a role in neuropathic pain following peripheral nerve injury in rats. Neuroscience (2004) 1.45

DNA methyltransferase inhibition enhances apoptosis induced by histone deacetylase inhibitors. Cancer Res (2001) 1.45

Solution structure of the cyclosporin A/cyclophilin complex by NMR. Nature (1993) 1.44

The circulatory responses to fibreoptic intubation: a comparison of oral and nasal routes. Anaesthesia (2006) 1.44

The mechanical effectiveness of erect and "bent-hip, bent-knee" bipedal walking in Australopithecus afarensis. J Hum Evol (1998) 1.41

Selected chitinase genes in cultured and uncultured marine bacteria in the alpha- and gamma-subclasses of the proteobacteria. Appl Environ Microbiol (2000) 1.41

Infusion of glycine does not attenuate in vivo ischemic acute renal failure in the rat. J Lab Clin Med (1993) 1.40

Cognitive impairment, decline and fluctuations in older community-dwelling subjects with Lewy bodies. Brain (2012) 1.40

Epstein-Barr virus reactivation in hairy leukoplakia. Mod Pathol (1996) 1.39

Cardiogenic shock with takotsubo-like cardiomyopathy in functional retroperitoneal paraganglioma. Herz (2014) 1.38

Selective nucleation and discovery of organic polymorphs through epitaxy with single crystal substrates. J Am Chem Soc (2001) 1.37

Biochemical and evolutionary significance of phospholipid methylation. J Biol Chem (1998) 1.37

Masking of Bacillus megaterium KM membrane reduced nicotinamide adenine dinucleotide oxidase and solubilization studies. J Bacteriol (1970) 1.36

Variants in KCNQ1 are associated with susceptibility to type 2 diabetes in the population of mainland China. Diabetologia (2009) 1.34

Molecular cloning of a rat kappa opioid receptor reveals sequence similarities to the mu and delta opioid receptors. Biochem J (1993) 1.34

Divalent cation activation of deoxycholate-solubilized and -inactivated membrane reduced nicotinamide adenine dinucleotide oxidase of Bacillus megaterium KM. J Bacteriol (1970) 1.33

Increased expression of unmethylated CDKN2D by 5-aza-2'-deoxycytidine in human lung cancer cells. Oncogene (2001) 1.30

Generation of high-titer defective HSV-1 vectors using an IE 2 deletion mutant and quantitative study of expression in cultured cortical cells. Biotechniques (1996) 1.28

A repressor sequence in the juxtamembrane domain of Flt-1 (VEGFR-1) constitutively inhibits vascular endothelial growth factor-dependent phosphatidylinositol 3'-kinase activation and endothelial cell migration. EMBO J (2000) 1.28

MicroRNA-193a represses c-kit expression and functions as a methylation-silenced tumor suppressor in acute myeloid leukemia. Oncogene (2011) 1.27

Initial results of screening of nondiabetic organ donors for expression of islet autoantibodies. J Clin Endocrinol Metab (2006) 1.27

Function and organization of photosystem I in a cyanobacterial mutant strain that lacks PsaF and PsaJ subunits. J Biol Chem (1994) 1.27

Kinetics of electron transfer between cardiac cytochrome c 1 and c. J Biol Chem (1973) 1.26

Mouse muscle nicotinic acetylcholine receptor gamma subunit: cDNA sequence and gene expression. Nucleic Acids Res (1986) 1.24

Genetic determination of islet cell autoimmunity in monozygotic twin, dizygotic twin, and non-twin siblings of patients with type 1 diabetes: prospective twin study. BMJ (1999) 1.23

RIG-E, a human homolog of the murine Ly-6 family, is induced by retinoic acid during the differentiation of acute promyelocytic leukemia cell. Proc Natl Acad Sci U S A (1996) 1.23

The major protein of GLUT4-containing vesicles, gp160, has aminopeptidase activity. J Biol Chem (1994) 1.23

Molecular cloning, tissue distribution and chromosomal localization of a novel member of the opioid receptor gene family. FEBS Lett (1994) 1.23

Macrophage and monocyte IL-1 beta regulation differs at multiple sites. Messenger RNA expression, translation, and post-translational processing. J Immunol (1992) 1.23

Mapping sites of interaction of p47-phox and flavocytochrome b with random-sequence peptide phage display libraries. Proc Natl Acad Sci U S A (1995) 1.23

Differential regulation by cAMP-dependent protein kinase and protein kinase C of the mu opioid receptor coupling to a G protein-activated K+ channel. J Biol Chem (1994) 1.22